How Will Valneva's COVID Vaccine Setback Impact Dynavax?

Several companies are using CpG 1018, an adjuvant developed by Dynavax Technologies (NASDAQ: DVAX), in developing their COVID-19 vaccines. One of them, French biotech Valneva (NASDAQ:VALN), has recently received some bad news with the U.K. canceling a supply deal. In this Motley Fool Live video recorded on Sept. 15, Motley Fool contributors Keith Speights and Brian Orelli discuss how Valneva's setback might impact Dynavax.